Novo Nordisk (NVO) reported Q1 earnings on May 2. Even though it was a positive report, sales of its weight-loss drug Wegovy came in below expectations, causing the NVO stock price to fall lower. The selloff may have been an initial and short-lived reaction, as NVO pivoted and gapped up…
Good morning and welcome to this week’s Flight Path. The equity “NoGo” trend struggled this week as prices climbed from…
EB Weekly Market Recap Video If you haven’t seen our latest weekend recording, it’s now available HERE at YouTube.com.…
Today Erin uncovers two industry groups that are showing strength and potential in the short term. She takes a…
In this edition of StockCharts TV‘s The Final Bar, Dave recaps another strong day for stocks as the S&P 500 regains…
We’ve all heard that popular Wall Street adage, “Go away in May”, right? It’s cute and it rhymes, so…
In this episode of StockCharts TV‘s The MEM Edge, Mary Ellen reviews the key drivers for this week’s volatile period, including…
As investors flock to Omaha, Nebraska in their annual pilgrimage to learn from the great Warren Buffett, it seems…